ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,178.96
1.84%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.733
0.11%
Brent Oil
83.615
0.59%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. vTv Therapeutics Inc (VTVT)

  7. vTv Therapeutics Inc (VTVT) ニュース

VTVT

vTv Therapeutics (VTVT)

vTv Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VTVT
日付受信時刻ニュースソース見出しコード企業名
2024/03/1921 : 30PR Newswire (US)CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMITNASDAQ:VTVTvTv Therapeutics Inc
2024/03/1321 : 00GlobeNewswire Inc.vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0806 : 47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0804 : 34Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0609 : 52Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0522 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0422 : 00GlobeNewswire Inc.vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 DiabetesNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0122 : 00GlobeNewswire Inc.vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:VTVTvTv Therapeutics Inc
2024/03/0109 : 34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTVTvTv Therapeutics Inc
2024/02/2823 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2024/02/2823 : 14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VTVTvTv Therapeutics Inc
2024/02/2822 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2024/02/2822 : 00GlobeNewswire Inc.vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundNASDAQ:VTVTvTv Therapeutics Inc
2024/02/2306 : 00PR Newswire (US)CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCENASDAQ:VTVTvTv Therapeutics Inc
2023/12/2306 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/12/2006 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/12/1306 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/2106 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/1522 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/1522 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/1006 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTVTvTv Therapeutics Inc
2023/11/1006 : 30GlobeNewswire Inc.vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:VTVTvTv Therapeutics Inc
2023/11/1006 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/0822 : 00GlobeNewswire Inc.vTv Therapeutics to Participate at the Stifel 2023 Healthcare ConferenceNASDAQ:VTVTvTv Therapeutics Inc
2023/11/0221 : 00GlobeNewswire Inc.vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical OfficerNASDAQ:VTVTvTv Therapeutics Inc
2023/11/0121 : 24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTVTvTv Therapeutics Inc
2023/11/0121 : 00GlobeNewswire Inc.vTv Therapeutics Announces Sale of Shares in Reneo Pharmaceuticals for Proceeds of $4.4 MillionNASDAQ:VTVTvTv Therapeutics Inc
2023/09/2721 : 30PR Newswire (US)CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19NASDAQ:VTVTvTv Therapeutics Inc
2023/09/2621 : 30PR Newswire (US)Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic CancerNASDAQ:VTVTvTv Therapeutics Inc
2023/09/2605 : 20Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:VTVTvTv Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VTVT

最近閲覧した銘柄

NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有